Satisfaction of Fentanyl nose spray administrated to decrease pain.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28012

Enrollment

Registered

2011-04-28

Start date

2010-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

break through pain fentanyl nose spray satisfaction doorbraakpijnen fentanyl neusspray tevredenheid

Interventions

A questionnaire is filled in by patients. No intervention will be given seen the patients are already using fentanyl.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged ≥ 18 years, either sex; 2. (Cancer)patient with pain; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy for opioids; 2. Acute or chronic nasal problems like rhinitis or sinusitis; 3. Azian female; 4. Patients with large facial injuries.

Design outcomes

Primary

Measure	Time frame
Satisfaction of patients using fentanyl nose spray determined by a questionnaire treatment satisfaction questionnaire for medication (TSQM).	—

Secondary

Measure	Time frame
Influence of several covariates of patients.	—

Contacts

Public ContactN. Veldhorst-Janssen

PO Box 5800

n.veldhorst@mumc.nl+31 (0)43 3876543

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)